Sanofi (SNY) Net Cash Flow (2009 - 2025)

Sanofi (SNY) has 10 years of Net Cash Flow data on file, last reported at -$2.5 billion in Q1 2026.

• Quarterly Net Cash Flow fell 425.76% year-over-year to -$2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 billion (changed 0.1% YoY) and the FY2025 annual result came in at $167.6 million, up 114.4% from the prior year.
• Net Cash Flow declined to -$2.5 billion in Q1 2026 per SNY's latest filing, from -$1.2 billion in the prior quarter.
• The five-year high for Net Cash Flow was $12.0 billion in Q4 2023, with the low at -$2.6 billion in Q2 2024.
• Average Net Cash Flow over 5 years is $3.1 billion, with a median of $1.3 billion recorded in 2022.
• Year-over-year, Net Cash Flow surged 412.42% in 2025 and plunged 425.76% in 2026.
• Sanofi's Net Cash Flow stood at $11.2 billion in 2022, then rose by 6.9% to $12.0 billion in 2023, then sank by 103.03% to -$362.3 million in 2024, then slumped by 221.33% to -$1.2 billion in 2025, then tumbled by 113.42% to -$2.5 billion in 2026.
• Business Quant data shows SNY's Net Cash Flow at -$2.5 billion in Q1 2026, -$1.2 billion in Q4 2025, and $1.6 billion in Q3 2025.